The Future of Cannabinoid Medicine Starts Here
HyGyHya Global Industries has solved the industry's most critical challenge — stabilizing cannabinoids for safe, consistent, and pharmaceutical-grade delivery worldwide.
The Molecule Behind It All
C₂₁H₃₀O₂
Cannabidiol is one of the most structurally complex phytocannabinoids in hemp. At Hygyhya, we start here — because understanding exactly what CBD is, and what threatens it, is the only honest way to protect it.
The Fragile Core
First to degrade
The double bond inside the cyclohexene ring — and the adjacent isopropenyl group — are the most chemically reactive sites on the molecule. Under light, heat, or trace acid, this region undergoes cyclisation, converting CBD into delta-8-THC and eventually into the inert cannabinoid CBN. Most products are degrading here before they ever reach a shelf.
The Phenolic Anchor
Oxidation's second target
The two hydroxyl groups on the benzene ring are what allow CBD to interact with the body's endocannabinoid receptors. They are also the second major oxidation target — once these degrade, the molecule loses biological activity entirely. Hygyhya's oxygen-barrier packaging and antioxidant-stabilised carriers are designed specifically to protect this site.
The Delivery Tail
Lipophilic by design
The five-carbon pentyl chain makes CBD fat-soluble — essential for crossing cell membranes and binding to receptors. It is also why standard water-based formulations waste the majority of their dose. Hygyhya pairs this chain with precision lipid carriers, so the intact, stable molecule reaches your system rather than the drain.
C₂₁H₃₀O₂
Our Innovation
The Micro Bio-Shield Platform
Six critical advantages that set stabilized cannabinoid delivery apart.
No THC Conversion
CBD naturally degrades into THC over time. Our Micro Bio-Shield creates a protective barrier that prevents this conversion entirely, ensuring full regulatory compliance at every stage of production.
3× Extended Shelf Life
Standard CBD loses potency within 117 days. Stabilized formulations maintain full efficacy for 351+ days.
SRM-Ready Batches
Every batch reaches 100% Standard Reference Material consistency — no variance between production runs.
Superior Bioavailability
Micro-encapsulation dramatically increases the percentage of cannabinoids that reach ECS receptors.
GRAS Compliant
Formulated exclusively with FDA Generally Recognized As Safe ingredients.
Global Market Access
Designed to satisfy international pharmaceutical regulatory standards worldwide.
Chief Science Officer
Dr. James Woodford
Scientific Leadership
The Science Behind the Shield
Dr. James Woodford brings decades of analytical chemistry expertise to HyGyHya Global Industries. His pioneering research in cannabinoid stability and Standard Reference Material development forms the scientific foundation of the Micro Bio-Shield platform.
A recognized authority in cannabinoid pharmacology, Dr. Woodford has worked alongside government agencies, academic institutions, and pharmaceutical companies to advance the science of safe, measurable cannabinoid delivery.
View Full ProfileTrusted By
Our Partners
Partner logos coming soon.